Much Ado About Nothing? A Real-World Study of Patients With Type 2 Diabetes Switching Basal Insulin Analogs

Advances in Therapy - United States
doi 10.1007/s12325-014-0120-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Much Ado About Nothing

Rechtsgeschichte
LawHistory
2012English

Much Ado About Nothing?

Circulation. Cardiovascular quality and outcomes
MedicineCardiovascular MedicineCardiology
2017English

Glycosylated Haemoglobin (A1c) Best Values for Type 2 Diabetes in the Battlefield Much Ado About Nothing? (Apparently)

Diabetology and Metabolic Syndrome
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Lawfare: A Current Threat or Much Ado About Nothing?

2013English

“Unfair” Dispute Resolution Clauses: Much Ado About Nothing?

English

Response to the Letters Addressing “Much Ado About Nothing”

CNS Spectrums
PsychiatryMental HealthNeurology
2017English

Clinical Benefits of Switching Type 2 Diabetes Patients From Human Insulins to Insulin Analogs

Problemy Endokrinologii
EndocrinologyMetabolismDiabetes
2013English

Microplastics in the Environment: Much Ado About Nothing? A Debate

2018English

Much Ado About Almost Nothing: Methods for Dealing With Limited Data

Journal of Mathematics and System Science
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy